| Literature DB >> 28473827 |
Dongli Rong1,2, Qingping Wu1, Mingfang Xu2, Jumei Zhang1, Shubo Yu1.
Abstract
Staphylococcus aureus is an important food-borne opportunistic pathogen that frequently causes severe blood and tissue infections or even fatal illnesses. Although S. aureus has been extensively studied in livestock and poultry foods in China, limited information has been reported in aquatic products. Accordingly, in this study, we aimed to characterize S. aureus in aquatic products purchased from retail markets in China. In total, 320 aquatic food samples were collected from 32 provincial capitals in China. The results showed that 119 samples (37.2%, 119/320) were positive for S. aureus by both qualitative and quantitative analyses. The contamination levels of 78.2% of samples ranged from 0.3 to 10 MPN/g, and six samples exceeded 110 MPN/g. A total of 119 S. aureus isolates from positive samples were selected to evaluate virulence factors, antibiotic resistance, and molecular characteristics. All S. aureus isolates were evaluated for the presence of 11 virulence genes by multiplex polymerase chain reaction, and α-hemolysin (hlα, 84.9%), fibronectin-binding protein A (fnbA, 79.0%), S. aureus enterotoxin E (see, 53.8%), and Panton-Valentine leucocidin (pvl, 50.4%) were identified as the major genes. These genes formed 56 different profiles, with the major profile identified as pvl-hlα-fnbA (28.6%). The antimicrobial susceptibility of all isolates was analyzed through the disk diffusion method, and the results showed high resistance to β-lactams, macrolides and tetracyclines, but susceptibility to linezolid and vancomycin. In addition, 26 sequence types (STs) were obtained via multilocus sequence typing, including seven novel STs, among which ST1 (20.2%), ST15 (18.5%), and ST188 (13.4%) were the most common STs. All the isolates were mecC negative, but nine isolates carrying mecA were evaluated by staphylococcal cassette chromosome mec (SCCmec) typing, all of which were SCCmecIII or SCCmecIV types. Isolates of SCCmecIII showed a high prevalence and were multidrug resistant. Our results showed that aquatic products could be a vehicle for transmission of virulence genes and multidrug-resistant S. aureus, representing a potential public health risk. The STs identified in this study indicated the genetic diversity of S. aureus, thereby providing important basic data for the dissemination of S. aureus in aquatic products.Entities:
Keywords: Staphylococcus aureus; antibiotic resistance; aquatic products; multilocus sequence typing; staphylococcal cassette chromosome mec; virulence genes
Year: 2017 PMID: 28473827 PMCID: PMC5398012 DOI: 10.3389/fmicb.2017.00714
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Prevalence of Staphylococcus aureus in retail aquatic products in China.
| Species of fish | No. of samples | No. of positive samples | Positive rate | No. of positive samples by quantitative methods (MPN/g) | |||
|---|---|---|---|---|---|---|---|
| 0.3–1 | 1–10 | 10–110 | >110 | ||||
| Freshwater fish | 142 | 74 | 52.1% | 25 | 29 | 15 | 5 |
| Saltwater fish | 113 | 27 | 23.9% | 18 | 6 | 2 | 1 |
| Shrimp | 65 | 18 | 27.7% | 10 | 5 | 3 | 0 |
| Total | 320 | 119 | 37.2% | 53 | 40 | 20 | 6 |
Virulence genes of S. aureus in retail aquatic products in China.
| Sources | Positive samples | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Freshwater fish | 74 | 15 | 7 | 25 | 8 | 38 | 41 | 62 | 4 | 57 | 12 | 3 |
| Saltwater fish | 27 | 9 | 4 | 9 | 5 | 13 | 15 | 23 | 2 | 21 | 3 | 0 |
| Shrimp | 18 | 3 | 1 | 8 | 3 | 13 | 4 | 16 | 2 | 16 | 3 | 0 |
| Total | 119 | 27 | 12 | 42 | 16 | 64 | 60 | 101 | 8 | 94 | 18 | 3 |
| Percentage (%) | 22.7 | 10.1 | 35.3 | 13.4 | 53.8 | 50.4 | 84.9 | 6.7 | 79.0 | 15.1 | 2.5 |
Results of antimicrobial resistance of S. aureus isolates in the study.
| Category | Antimicrobial agents | |||
|---|---|---|---|---|
| Resistant (R) | Intermediate (I) | Susceptible (S) | ||
| Ampicillin (10 μg) | 105 (88.2%) | 0 (0.0%) | 14 (11.8%) | |
| Penicllin G (10 units) | 105 (88.2%) | 0 (0.0%) | 14 (11.8%) | |
| Amoxicillin-clavulanic acid (30 μg) | 88 (73.9%) | 0 (0.0%) | 31 (26.1%) | |
| Cefoxitin (30 μg) | 10 (8.4%) | 0 (0.0%) | 109 (91.6%) | |
| Ceftazidime (30 μg) | 13 (10.9%) | 0 (0.0%) | 106 (89.1%) | |
| Cefepime (30 μg) | 10 (8.4%) | 0 (0.0%) | 109 (91.6%) | |
| Kanamycin (30 μg) | 27 (22.7%) | 7 (5.9%) | 85 (71.4%) | |
| Streptomycin (10 μg) | 17 (14.3%) | 6 (5.0%) | 96 (80.7%) | |
| Amikacin (30 μg) | 2 (1.7%) | 0 (0.0%) | 117 (98.3%) | |
| Gentamicin (10 μg) | 5 (4.2%) | 1 (0.8%) | 113 (95.0%) | |
| Norfloxacin (10 μg) | 8 (6.7%) | 8 (6.7%) | 103 (86.6%) | |
| Ciprofloxacin(5 μg) | 6 (5.0%) | 3 (2.5%) | 110 (92.5%) | |
| Quinupristin/dalfopristin (15 μg) | 3 (2.5%) | 0 (0.0%) | 116 (97.5%) | |
| Erythromycin (15 μg) | 64 (53.8%) | 5 (4.2%) | 50 (42.0%) | |
| Telithromycin (15 μg) | 10 (8.4%) | 4 (3.4%) | 105 (88.2%) | |
| Tetracycline (30 μg) | 36 (26.9%) | 1 (0.8%) | 82 (68.9%) | |
| Clindamycin (2 μg) | 15 (12.6%) | 3 (2.5%) | 101 (84.9%) | |
| Chloramphenicol (30 μg) | 9 (7.5%) | 1 (0.8%) | 109 (91.6%) | |
| Trimethoprim-sulfamethoxazole (25 μg) | 9 (7.5%) | 0 (0.0%) | 110 (92.5%) | |
| Linezolid (30 μg) | 0 (0.0%) | 0 (0.0%) | 119 (100.0%) | |
| Vancomycin (MIC) | 0 (0.0%) | 0 (0.0%) | 119 (100.0%) | |
| Rifampicin (5 μg) | 3 (2.5%) | 0 (0.0%) | 116 (97.5%) | |
| Fusidic acid (10 μg) | 4 (3.4%) | 0 (0.0%) | 115 (96.6%) | |
| Fosfomycin (200 μg) | 1 (0.8%) | 7 (5.9%) | 111 (93.3%) | |
| ≥3 Antimicrobia | 108 (90.6%) | |||
| ≥6 Antimicrobia | 39 (30.3%) | |||
| ≥9 Antimicrobia | 7 (5.9%) | |||